Newsletter

Soft-Tissue Sarcoma
A rare tumor, Soft Tissue Sarcoma is anticipated to witness a promising pipeline of therapeutics in the next decade.
Soft-tissue sarcoma

More Whitepapers / Newsletters

Cancer Care In The Time Of COVID
Cancer Care In The Time Of COV...

The coronavirus outbreak has affected thousands of people in at least 186 countries which has also affected the cancer care delivery system apart from affecting the overall health system. Cancer patie...

Current Treatment Challenges Of IO Refractory Patients And Clinical Development Of Therapies Targeting These Patients
Current Treatment Challenges O...

Over the years, the Oncology domain has experienced the entry of several treatment approaches. Therapeutic approaches such as surgery, radiation therapy, and chemotherapy form the conventional methods...

Immune Thrombocytopenic Purpura (ITP)
Immune Thrombocytopenic Purpur...

Immune thrombocytopenic purpura (ITP) is a disorder that results in the immune system killing its platelets. It results in excessive bleeding or bruising easily due to low levels of platelets. Worldwi...

Biosimilars: Evidence From Europe
Biosimilars: Evidence From Eur...

The EU market contains more than 55 biosimilars for around 15 oncology, autoimmune, diabetes, and fertility biologic therapies. Although the expiry of patent protection for biologics has resulted in i...

Anorexia Nervosa Market
Anorexia Nervosa

Anorexia Nervosa (AN) is a psychological condition that is characterized by an abnormally low weight, intense fear of gaining weight and distorted perception of body weight. It is prevalent in all dev...